The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
A common haplotype in the complement regulatory gene factor H ( HF1/CFH ) predisposes individuals to age-related macular degeneration
Open accessAbstract
Age-related macular degeneration (AMD) is the most frequent cause of irreversible blindness in the elderly in developed countries. Our previous studies implicated activation of complement in the formation of drusen, the hallmark lesion of AMD. Here, we show that factor H (HF1), the major inhibitor of the alternative complement pathway, accumulates within drusen and is synthesized by the retinal pigmented epithelium. Because previous linkage analyses identified chromosome 1q25-32, which harbors the factor H gene ( HF1 / CFH ), as an AMD susceptibility locus, we analyzed HF1 for genetic variation in two independent cohorts comprised of ≈900 AMD cases and 400 matched controls. We found association of eight common HF1 SNPs with AMD; two common missense variants exhibit highly significant associations (I62V, χ 2 = 26.1 and P = 3.2 × 10 -7 and Y402H, χ 2 = 54.4 and P = 1.6 × 10 -13 ). Haplotype analysis reveals that multiple HF1 variants confer elevated or reduced risk of AMD. One common at-risk haplotype is present at a frequency of 50% in AMD cases and 29% in controls [odds ratio (OR) = 2.46, 95% confidence interval (1.95-3.11)]. Homozygotes for this haplotype account for 24% of cases and 8% of controls [OR = 3.51, 95% confidence interval (2.13-5.78)]. Several protective haplotypes are also identified (OR = 0.44-0.55), further implicating HF1 function in the pathogenetic mechanisms underlying AMD. We propose that genetic variation in a regulator of the alternative complement pathway, when combined with a triggering event, such as infection, underlie a major proportion of AMD in the human population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A major AMD-associated SNP is the Y402H (tyrosine to histidine substitution at amino acid 402) variant of complement factor H (CFH) (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Hageman et al., 2005
In the citing paper
“These SNPs have been reported to be major genetic factors for developing AMD in Caucasians (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Tuo et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Hageman et al., 2005
In the citing paper
“These findings are consistent with findings in drusen of humans with AMD (Hageman et al., 2005), as well as the critical role in AMD of complement overactivity, which has been discussed above.”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Hageman et al., 2005
In the citing paper
“Complement activation playing a major role in AMD pathogenesis is yet another source of inflammation [107-110].”
From Risk mitigation of immunogenicity: a key to personalized retinal gene therapy (2021) · cites this paper as [107]
In the citing paper
“Polymorphisms in human complement regulatory factor H (CFH) predispose individuals to AMD [35, 46, 59]”
From Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain (2022) · cites this paper as [46]
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [10]
In the citing paper
“This analysis resulted in the identification of the previously well documented independently associated variants near CFH and C2/CFB8,10,31,32 and of additional independent signals near C3, CETP, LIPC, FRK/COL10A1, IER3/DDR1, RAD51B (Supplementary Table 6).”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [10]
In the citing paper
“Initial reports of association included candidate gene approach, fine mapping of candidate loci, and the first successful whole-genome association study in humans (40, 63, 65, 95) and were immediately replicated (175).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [63]
In the citing paper
“More recently, several studies have found an association between advanced age-related macular degeneration and complement factor H, an integral component of the alternative pathway of complement activation.54–65”
From Age-related macular degeneration (2008) · cites this paper as [57]
In the citing paper
“Biochemical analysis of drusen have indeed resulted in identification of complement components and inflammatory modulators [2–8].”
From CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD (2005) · cites this paper as [3]
In the citing paper
“CFH protein has been detected in choriocapillaris and within soft drusen [3].”
From CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD (2005) · cites this paper as [3]
In the citing paper
“The addition of markers within the linkage peak led to recent reports by five groups that there is an association between a common missense variant (Y402H) in CFH and AMD in the United States [3,16–19].”
From CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD (2005) · cites this paper as [3]
In the citing paper
“The Y402H allele was present in at least 60% of AMD patients with risk ratios of between 2.0 and 3.5 for one risk allele, and with risk ratios of between 3.3 and 7.4 for carriers of two risk alleles.”
From CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD (2005) · cites this paper as [3]
In the citing paper
“However, the question of how the Y402H allele contributes to the different subtypes of AMD has not been properly addressed, owing either to insufficient clinical information or to sample size, as neovascular AMD dominates the patient cohorts in most previously reported studies [3,16–19].”
From CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD (2005) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Bird, A. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P. T. V. M., Klaver, C. C. W., Klein, B. E. K., Klein, R., et al. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80092-x · Cited by 1,926
Self-citationHageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Self-citationDrusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208
A role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Self-citationMullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
Self-citationThe epidemiology of age-related macular degeneration
Klein, R., Peto, T., Bird, A., & Vannewkirk, M. R. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.069 · Cited by 932
Mutation of the Stargardt Disease Gene ( ABCR ) in Age-Related Macular Degeneration
Allikmets, R. L., Shroyer, N. F., Singh, N., Seddon, J. M., Lewis, R. A., Bernstein, P. S., Peiffer, A. P., Zabriskie, N. A., Li, Y., Hutchinson, A. A., et al. (1997) · Science · doi:10.1126/science.277.5333.1805 · Cited by 879
Self-citationSystematic Identification and Analysis of Exonic Splicing Silencers
Wang, Z., Rolish, M. E., Yeo, G. W.-M., Tung, V., Mawson, M., & Burge, C. B. (2004) · Cell · doi:10.1016/j.cell.2004.11.010 · Cited by 678
Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Klaver, C. C., Assink, J. J., van Leeuwen, R., Wolfs, R. C., Vingerling, J. R., Stijnen, T., Hofman, A. & de Jong, P. T. (2001) Invest. Ophthalmol. Visual Sci. 42, 2237-2241.11527936
- Hu, J. & Bok, D. (2001) Mol. Vision 7, 14-19.
Cited by
Sorted by citations
Items 101–191 of 191
Bhutto, I. A., Baba, T., Merges, C., Juriasinghani, V., McLeod, D. S., & Lutty, G. A. (2011) · British Journal of Ophthalmology · doi:10.1136/bjo.2010.199216 · Cited by 126
Clark, S. J., Schmidt, C. Q., White, A. M., Hakobyan, S., Morgan, B. P., & Bishop, P. N. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401613 · Cited by 122
Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD
Hadziahmetovic, M., Dentchev, T., Song, Y., Haddad, N., He, X., Hahn, P., Pratico, D., Wen, R., Harris, Z. L., Lambris, J. D., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1472 · Cited by 121
Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD
Kloeckener-Gruissem, B., Barthelmes, D., Labs, S., Schindler, C., Kurz-Levin, M., Michels, S., Fleischhauer, J., Berger, W., Sutter, F., & Menghini, M. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6080 · Cited by 120
Cashman, S. M., Ramo, K., & Kumar-Singh, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019078 · Cited by 118
Ebrahem, Q., Renganathan, K., Sears, J., Vasanji, A., Gu, X., Lu, L., Salomon, R. G., Crabb, J. W., & Anand-Apte, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601552103 · Cited by 117
Cameron, D. J., Yang, Z., Gibbs, D., Chen, H., Kaminoh, Y., Jorgensen, A., Zeng, J., Luo, L., Brinton, E., Brinton, G., et al. (2007) · Cell Cycle · doi:10.4161/cc.6.9.4157 · Cited by 114
Tuo, J., Ning, B., Bojanowski, C. M., Lin, Z.-N., Ross, R. J., Reed, G. F., Shen, D., Jiao, X., Zhou, M., Chew, E. Y., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603485103 · Cited by 114
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
Skeie, J. M., Fingert, J. H., Russell, S. R., Stone, E. M., & Mullins, R. F. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5322 · Cited by 114
Self-citationLipids, oxidized lipids, oxidation-specific epitopes, and Age-related macular degeneration.
Handa, J. T., Cano, M., Wang, L., Datta, S., & Liu, T. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.07.013 · Cited by 112
DeAngelis, M. M., Ji, F., Adams, S., Morrison, M. A., Harring, A. J., Sweeney, M. O., Capone, A., Miller, J. W., Dryja, T. P., Ott, J., et al. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.10.032 · Cited by 104
The challenges and promise of complement therapeutics for ocular diseases
Park, D. H., Connor, K. M., & Lambris, J. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01007 · Cited by 108
Vogt, S. D., Curcio, C. A., Wang, L., Li, C.-M., McGwin, G., Medeiros, N. E., Philp, N. J., Kimble, J. A., & Read, R. W. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.06.002 · Cited by 104
Inflammation, Complement Factor H, and Age-Related Macular Degeneration
Klein, R., Knudtson, M. D., Klein, B. E. K., Wong, T. Y., Cotch, M. F., Liu, K., Cheng, C. Y., Burke, G. L., Saad, M. F., Jacobs, D. R., et al. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.03.021 · Cited by 106
Mouse models of age-related macular degeneration
Elizabeth Rakoczy, P., Yu, M. J. T., Nusinowitz, S., Chang, B., & Heckenlively, J. R. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.10.012 · Cited by 107
On the origin of proteins in human drusen: The meet, greet and stick hypothesis
Bergen, A. A., Arya, S., Koster, C., Pilgrim, M. G., Wiatrek-Moumoulidis, D., van der Spek, P. J., Hauck, S. M., Boon, C. J. F., Emri, E., Stewart, A. J., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.12.003 · Cited by 101
Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD)
Baird, P. N., Richardson, A. J., Robman, L. D., Dimitrov, P. N., Tikellis, G., McCarty, C. A., & Guymer, R. H. (2006) · Human Mutation · doi:10.1002/humu.20288 · Cited by 105
Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration
Spencer, K. L., Hauser, M. A., Olson, L. M., Schmidt, S., Scott, W. K., Gallins, P., Agarwal, A., Postel, E. A., Pericak-Vance, M. A., & Haines, J. L. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm369 · Cited by 102
The proteome of central and peripheral retina with progression of age-related macular degeneration
Ethen, C. M., Reilly, C., Feng, X., Olsen, T. W., & Ferrington, D. A. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1395 · Cited by 99
Chen, M., Muckersie, E., Robertson, M., Forrester, J. V., & Xu, H. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.09.005 · Cited by 99
Complement Component C3 and Risk of Age-Related Macular Degeneration
Despriet, D. D. G., van Duijn, C. M., Oostra, B. A., Uitterlinden, A. G., Hofman, A., Wright, A. F., ten Brink, J. B., Bakker, A., de Jong, P. T. V. M., Vingerling, J. R., et al. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.09.055 · Cited by 94
Self-citationGenetics of age-related macular degeneration: current concepts, future directions
DeAngelis, M. M., Silveira, A. C., Carr, E. A., & Kim, I. K. (2011) · Seminars in Ophthalmology · doi:10.3109/08820538.2011.577129 · Cited by 94
Properdin and factor h: Opposing players on the alternative complement pathway “see-saw”
Kouser, L., Abdul-Aziz, M., Nayak, A., Stover, C. M., Sim, R. B., & Kishore, U. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00093 · Cited by 91
Francis, P. J., George, S., Schultz, D. W., Rosner, B., Hamon, S., Ott, J., Weleber, R. G., Klein, M. L., & Seddon, J. M. (2007) · Human Heredity · doi:10.1159/000100046 · Cited by 91
Baird, P. N., Robman, L. D., Richardson, A. J., Dimitrov, P. N., Tikellis, G., McCarty, C. A., & Guymer, R. H. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn018 · Cited by 90
Complement factor H binds to denatured rather than to native pentameric C-reactive protein
Hakobyan, S., Harris, C. L., van den Berg, C. W., Fernandez-Alonso, M. C., de Jorge, E. G., de Cordoba, S. R., Rivas, G., Mangione, P., Pepys, M. B., & Morgan, B. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803648200 · Cited by 90
Cackett, P., Wong, T. Y., Aung, T., Saw, S.-M., Tay, W. T., Rochtchina, E., Mitchell, P., & Wang, J. J. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.06.026 · Cited by 87
Self‐nonself discrimination by the complement system
Meri, S. (2016) · FEBS Letters · doi:10.1002/1873-3468.12284 · Cited by 87
Hijacking Factor H for Complement Immune Evasion
Moore, S. R., Menon, S. S., Cortes, C., & Ferreira, V. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.602277 · Cited by 83
Kaur, I., Hussain, A., Hussain, N., Das, T., Pathangay, A., Mathai, A., Hussain, A., Nutheti, R., Nirmalan, P. K., & Chakrabarti, S. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1430 · Cited by 84
Defective lipid transport and biosynthesis in recessive and dominant Stargardt macular degeneration
Molday, R. S., & Zhang, K. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.002 · Cited by 82
A local complement response by RPE causes early-stage macular degeneration
Fernandez-Godino, R., Garland, D. L., & Pierce, E. A. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv287 · Cited by 73
Nischler, C., Oberkofler, H., Ortner, C., Paikl, D., Riha, W., Lang, N., Patsch, W., & Egger, S. F. (2011) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2010.02080.x · Cited by 81
Interleukin-8 promoter polymorphism -251A/T is a risk factor for age-related macular degeneration
Goverdhan, S. V., Ennis, S., Hannan, S. R., Madhusudhana, K. C., Cree, A. J., Luff, A. J., & Lotery, A. J. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.123190 · Cited by 79
Sobrin, L., Reynolds, R., Yu, Y., Fagerness, J., Leveziel, N., Bernstein, P. S., Souied, E. H., Daly, M. J., & Seddon, J. M. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.08.015 · Cited by 78
Schaumberg, D. A. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.3.300 · Cited by 79
Lueck, K., Wasmuth, S., Williams, J., Hughes, T. R., Morgan, B. P., Lommatzsch, A., Greenwood, J., Moss, S. E., & Pauleikhoff, D. (2011) · Eye · doi:10.1038/eye.2011.109 · Cited by 80
Complement activation levels are related to disease stage in AMD
Heesterbeek, T. J., Lechanteur, Y. T. E., Lorés-Motta, L., Schick, T., Daha, M. R., Altay, L., Liakopoulos, S., Smailhodzic, D., den Hollander, A. I., Hoyng, C. B., et al. (2020) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.61.3.18 · Cited by 76
Hallam, D., Collin, J., Bojic, S., Chichagova, V., Buskin, A., Xu, Y., Lafage, L., Otten, E. G., Anyfantis, G., Mellough, C., et al. (2017) · Stem Cells · doi:10.1002/stem.2708 · Cited by 75
Ross, R. J., Bojanowski, C. M., Wang, J. J., Chew, E. Y., Rochtchina, E., Ferris, F. L., Mitchell, P., Chan, C.-C., & Tuo, J. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0999 · Cited by 75
Vogt, S. D., Barnum, S. R., Curcio, C. A., & Read, R. W. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.04.002 · Cited by 71
Implications of genetic variation in the complement system in age-related macular degeneration
de Jong, S., Gagliardi, G., Garanto, A., de Breuk, A., Lechanteur, Y. T. E., Katti, S., van den Heuvel, L. P., Volokhina, E. B., & den Hollander, A. I. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100952 · Cited by 71
Kunchithapautham, K., & Rohrer, B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.214593 · Cited by 71
The LOC387715 Polymorphism, Inflammatory Markers, Smoking, and Age-Related Macular Degeneration
Wang, J. J., Ross, R. J., Tuo, J., Burlutsky, G., Tan, A. G., Chan, C.-C., Favaloro, E. J., Williams, A., & Mitchell, P. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.05.038 · Cited by 69
Genetics and genetic testing for age-related macular degeneration
Warwick, A., & Lotery, A. (2018) · Eye · doi:10.1038/eye.2017.245 · Cited by 67
Coughlin, B., Schnabolk, G., Joseph, K., Raikwar, H., Kunchithapautham, K., Johnson, K., Moore, K., Wang, Y., & Rohrer, B. (2016) · Scientific Reports · doi:10.1038/srep23794 · Cited by 65
A Perspective of AMD Through the Eyes of Immunology
Copland, D. A., Theodoropoulou, S., Liu, J., & Dick, A. D. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.18-23893 · Cited by 66
Keenan, T. D. L., Pickford, C. E., Holley, R. J., Clark, S. J., Lin, W., Dowsey, A. W., Merry, C. L., Day, A. J., & Bishop, P. N. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.14-14126 · Cited by 65
Tuo, J., Ross, R. J., Reed, G. F., Yan, Q., Wang, J. J., Bojanowski, C. M., Chew, E. Y., Feng, X., Olsen, T. W., Ferris, F. L., et al. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.05.021 · Cited by 63
Rohrer, B., Coughlin, B., Kunchithapautham, K., Long, Q., Tomlinson, S., Takahashi, K., & Holers, V. M. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2010.12.016 · Cited by 62
Despriet, D. D. G., Bergen, A. A. B., Merriam, J. E., Zernant, J., Barile, G. R., Smith, R. T., Barbazetto, I. A., van Soest, S., Bakker, A., de Jong, P. T. V. M., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0656 · Cited by 60
Self-citationDwyer, M. A., Kazmin, D., Hu, P., McDonnell, D. P., & Malek, G. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0392 · Cited by 61
Ross, R. J., Zhou, M., Shen, D., Fariss, R. N., Ding, X., Bojanowski, C. M., Tuo, J., & Chan, C.-C. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.01.014 · Cited by 60
Orlin, A., Hadley, D., Chang, W., Ho, A. C., Brown, G., Kaiser, R. S., Regillo, C. D., Godshalk, A. N., Lier, A., Kaderli, B., et al. (2012) · Retina · doi:10.1097/iae.0b013e31822a2c7c · Cited by 60
The Role of the Classical Complement Cascade in Synapse Loss During Development and Glaucoma
Rosen, A. M., & Stevens, B. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-5635-4_6 · Cited by 60
Hallam, T. M., Marchbank, K. J., Harris, C. L., Osmond, C., Shuttleworth, V. G., Griffiths, H., Cree, A. J., Kavanagh, D., & Lotery, A. J. (2020) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.61.6.18 · Cited by 57
Zeng, S., Whitmore, S. S., Sohn, E. H., Riker, M. J., Wiley, L. A., Scheetz, T. E., Stone, E. M., Tucker, B. A., & Mullins, R. F. (2016) · The Journal of Pathology · doi:10.1002/path.4669 · Cited by 56
Synthesis and Propagation of Complement C3 by Microglia/Monocytes in the Aging Retina
Rutar, M., Valter, K., Natoli, R., & Provis, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093343 · Cited by 56
Feng, X., Xiao, J., Longville, B., Tan, A. X. J., Wu, X. N., Cooper, M. N., McAllister, I. L., Isaacs, T., Palmer, L. J., & Constable, I. J. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.03.011 · Cited by 54
Bao, L., Wang, Y., Chang, A., Minto, A. W., Zhou, J., Kang, H., Haas, M., & Quigg, R. J. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006101176 · Cited by 51
Seitsonen, S. P., Järvelä, I. E., Meri, S., Tommila, P. V., Ranta, P. H., & Immonen, I. J. (2007) · European Journal of Ophthalmology · doi:10.1177/112067210701700612 · Cited by 48
Cherepanoff, S., Mitchell, P., Wang, J. J., & Gillies, M. C. (2006) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2006.01281.x · Cited by 47
Montes, T., Goicoechea de Jorge, E., Ramos, R., Gomà, M., Pujol, O., Sánchez-Corral, P., & Rodríguez de Córdoba, S. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.01.027 · Cited by 47
Khandhadia, S., Hakobyan, S., Heng, L. Z., Gibson, J., Adams, D. H., Alexander, G. J., Gibson, J. M., Martin, K. R., Menon, G., Nash, K., et al. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.01.004 · Cited by 47
Hammadi, S., Tzoumas, N., Ferrara, M., Meschede, I. P., Lo, K., Harris, C., Lako, M., & Steel, D. H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082870 · Cited by 44
Lynch, A. M., Mandava, N., Patnaik, J. L., Frazer-Abel, A. A., Wagner, B. D., Palestine, A. G., Mathias, M. T., Siringo, F. S., Cathcart, J. N., & Holers, V. M. (2020) · European Journal of Ophthalmology · doi:10.1177/1120672119857896 · Cited by 44
Radu, R. A., Hu, J., Jiang, Z., & Bok, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.548669 · Cited by 44
Peroxisome proliferator-activated receptor and age-related macular degeneration
Herzlich, A. A., Tuo, J., & Chan, C.-C. (2008) · PPAR Research · doi:10.1155/2008/389507 · Cited by 43
The proteoglycan glycomatrix: A sugar microenvironment essential for complement regulation
Clark, S. J., Bishop, P. N., & Day, A. J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00412 · Cited by 39
Retinal pigment epithelial cells mitigate the effects of complement attack by endocytosis of C5b-9
Georgiannakis, A., Burgoyne, T., Lueck, K., Futter, C., Greenwood, J., & Moss, S. E. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500937 · Cited by 41
Complement inhibitors for age-related macular degeneration
Tzoumas, N., Riding, G., Williams, M. A., & Steel, D. H. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009300.pub3 · Cited by 38
Ramo, K., Cashman, S. M., & Kumar-Singh, R. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2025 · Cited by 38
Schnabolk, G., Coughlin, B., Joseph, K., Kunchithapautham, K., Bandyopadhyay, M., O'Quinn, E. C., Nowling, T., & Rohrer, B. (2015) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.14-15910 · Cited by 37
Tzoumas, N., Hallam, D., Harris, C. L., Lako, M., Kavanagh, D., & Steel, D. H. W. (2021) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2020.10.008 · Cited by 33
Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases
Recalde, S., Tortajada, A., Subias, M., Anter, J., Blasco, M., Maranta, R., Coco, R., Pinto, S., Noris, M., García-Layana, A., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050580 · Cited by 32
Chen, G., Tzekov, R., Li, W., Jiang, F., Mao, S., & Tong, Y. (2015) · Scientific Reports · doi:10.1038/srep14517 · Cited by 31
Sobrin, L., Maller, J. B., Neale, B. M., Reynolds, R. C., Fagerness, J. A., Daly, M. J., & Seddon, J. M. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.185 · Cited by 31
Genetic Aspects of Age-Related Macular Degeneration and Their Therapeutic Potential
Stradiotto, E., Allegrini, D., Fossati, G., Raimondi, R., Sorrentino, T., Tripepi, D., Barone, G., Inforzato, A., & Romano, M. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113280 · Cited by 29
Familial aggregation of age-related macular degeneration in the Utah population
Luo, L., Harmon, J., Yang, X., Chen, H., Patel, S., Mineau, G., Yang, Z., Constantine, R., Buehler, J., Kaminoh, Y., et al. (2008) · Vision Research · doi:10.1016/j.visres.2007.11.013 · Cited by 26
Bringing age-related macular degeneration into focus
Allikmets, R., & Dean, M. (2008) · Nature Genetics · doi:10.1038/ng0708-820 · Cited by 26
Hu, J., & Bok, D. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60327-325-1_2 · Cited by 24
Viral-vector-delivered anti-angiogenic therapies to the eye
Koponen, S., Kokki, E., Kinnunen, K., & Ylä-Herttuala, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020219 · Cited by 24
Complement factor H and related proteins in age-related macular degeneration
Calippe, B., Guillonneau, X., & Sennlaub, F. (2014) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2013.12.003 · Cited by 18
Risk mitigation of immunogenicity: a key to personalized retinal gene therapy
Varin, J., Morival, C., Maillard, N., Adjali, O., & Cronin, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312818 · Cited by 19
Complement Factor B Mediates Ocular Angiogenesis through Regulating the VEGF Signaling Pathway
Murray, H., Qiu, B., Ho, S. Y., & Wang, X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179580 · Cited by 16
Loeven, M. A., van Gemst, J. J., Schophuizen, C. M. S., Tilakaratna, V., van den Heuvel, L. P., Day, A. J., Klevering, B. J., & van der Vlag, J. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.iovs-17-22893 · Cited by 17
Bringing the genetics of macular degeneration into focus
Haines, J. L., Spencer, K. M., & Pericak-Vance, M. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708151104 · Cited by 15
Pharmacogenetics and Age-Related Macular Degeneration
Schwartz, S. G., & Brantley, M. A. (2011) · Journal of Ophthalmology · doi:10.1155/2011/252549 · Cited by 15
Complement C5 is not critical for the formation of sub-RPE deposits in Efemp1 mutant mice
Garland, D. L., Pierce, E. A., & Fernandez-Godino, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-89978-8 · Cited by 14
Medina, F. M. C., Motta, A. A. L. D., Takahashi, W. Y., Carricondo, P. C., Motta, M. M. D. S., Melo, M. B., & Vasconcellos, J. P. C. (2019) · Ophthalmic Research · doi:10.1159/000475995 · Cited by 12
Rapid Dissection of the Genetic Risk of Age-Related Macular Degeneration
Haines, J. L., & Pericak-Vance, M. A. (2007) · JAMA · doi:10.1001/jama.297.4.401 · Cited by 5
Metadata
- Authors
- Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., Smith, R. J. H., Silvestri, G., Russell, S. R., Klaver, C. C. W., Barbazetto, I., Chang, S., Yannuzzi, L. A., Barile, G. R., Merriam, J. C., Smith, R. T., Olsh, A. K., Bergeron, J., Zernant, J., Merriam, J. E., Gold, B., Dean, M., & Allikmets, R.
- Affiliations
- Queen's University Belfast (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-05-03
- Volume
- 102
- Issue
- 20
- Pages
- 7227-7232
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1088171
- OpenAlex
- W2125236492
- Cited by
- 1,961
- References
- 58
- Citations by year
- 2026: 22 · 2025: 45 · 2024: 43 · 2023: 37 · 2022: 75 · 2021: 78 · 2020: 67 · 2019: 50 · 2018: 59 · 2017: 60 · 2016: 78 · 2015: 105 · 2014: 111 · 2013: 117 · 2012: 116
- FWCI
- 146.43
- Type
- journal article
- Language
- en
- Open access
- green
- dx.doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Funders
- U.S. Department of Health and Human Services
- Research to Prevent Blindness
- Retina Research Foundation
- Queen's University
- National Institutes of Health (n01co12400-79-0-22, NO1-CO12400)
- National Eye Institute (EY11515, R01EY013435, EY-13435, R01EY011521, EY 11-521, R01EY011527, R01EY011515, EY11527)
- National Cancer Institute (N01CO12400, N01-CO-012400)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- age-related macular degeneration, complement factor H, complement regulatory proteins, alternative complement pathway, drusen, retinal pigment epithelium, haplotype association, single nucleotide polymorphisms, genetic susceptibility, missense mutations, complement activation
- MeSH terms
- Aged, Aged, 80 and over, DNA Mutational Analysis, Genotype, Haplotypes, Humans, Immunohistochemistry, Macular Degeneration, Middle Aged, Pigment Epithelium of Eye, Risk Factors, Genetic Variation, Odds Ratio, Complement Factor H, Mutation, Missense, Polymorphism, Single Nucleotide, Gene Components, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
